바이오뱅크 시장 : 세계 산업 규모, 점유율, 동향, 경쟁, 기회, 예측 - 유형별, 샘플 유형별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Biobanks Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, Segmented By Type, By Sample Type, By Application, By End User, By Region, and By Competition, 2020-2030F

US $ 4,500 ￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 바이오뱅크 시장은 2024년에 793억 4,000만 달러로 평가되었으며, 2030년까지 CAGR 8.98%로 성장하여 1,329억 1,000만 달러에 달할 것으로 예측됩니다.

바이오뱅크는 주로 연구 목적으로 혈액, 조직 등의 생물학적 물질과 관련 임상 데이터 및 인구통계학적 데이터를 보관하는 조직화된 저장소입니다. 세계 바이오뱅크 시장의 성장은 만성질환의 증가, 맞춤형 의료의 획기적인 발전, 생물의학 연구 및 신약개발 이니셔티브에 대한 투자 확대에 의해 근본적으로 촉진되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	793억 4,000만 달러
시장 규모 : 2030년	1,329억 1,000만 달러
CAGR : 2025-2030년	8.98%
가장 빠르게 성장하는 부문	질환 지향형 바이오뱅크
최대 시장	북미

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 바이오뱅크 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(질환 지향형 바이오뱅크, 집단 기반형 바이오뱅크, 조직 바이오뱅크, 기타)
  • 샘플 유형별(혈액제재, 생체액, 핵산, 세포주, 기타)
  • 용도별(치료제, Drug Discovery, 임상 진단, 임상 조사)
  • 최종사용자별(학술·연구기관, 제약·바이오테크놀러지 기업, 병원·진료소, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 바이오뱅크 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 바이오뱅크 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 바이오뱅크 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 바이오뱅크 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 바이오뱅크 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 바이오뱅크 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Danaher Corporation
• Merck KgaA
• Becton, Dickinson, and Company
• Avantor, Inc.
• Thermo Fisher Scientific, Inc
• Tecan Trading AG
• QIAGEN N.V.
• Hamilton Company
• ProMedDx, LLC
• ISENET Biobanking S.r.l

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Biobanks Market, valued at USD 79.34 Billion in 2024, is projected to experience a CAGR of 8.98% to reach USD 132.91 Billion by 2030. Biobanks are organized repositories storing biological materials, such as blood and tissue, along with associated clinical and demographic data, primarily for research purposes. The global biobanks market growth is fundamentally driven by the increasing prevalence of chronic diseases, significant advancements in personalized medicine, and rising investments in biomedical research and drug discovery initiatives.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 79.34 Billion
Market Size 2030	USD 132.91 Billion
CAGR 2025-2030	8.98%
Fastest Growing Segment	Disease Oriented Biobanks
Largest Market	North America

Key Market Drivers

The increased demand for high-quality biospecimens in research represents a primary market driver, stemming from the critical need for reliable biological materials in scientific inquiry. The integrity and standardized processing of samples are crucial for producing reproducible research outcomes across diverse disciplines including oncology, neuroscience, and infectious diseases. This stringent demand compels biobanks to implement rigorous quality control measures and advanced storage protocols. According to a July 2024 arXiv article, "Quantifying the Impact of Biobanks and Cohort Studies", 2,663 unique biobanks were mentioned across 228,761 scientific articles as of October 2023, underscoring their critical role in research dissemination and impact. This extensive utilization demonstrates the sustained reliance of the scientific community on robust biospecimen repositories to advance medical understanding.

Key Market Challenges

The substantial upfront capital expenditure required for establishing and maintaining modern biobanking facilities presents a significant challenging factor. This financial barrier directly impedes the expansion of the global biobanks market by limiting the entry of new organizations and restricting the growth capabilities of smaller existing entities. Establishing a biobank necessitates considerable investment in specialized infrastructure, advanced equipment for sample processing and long-term storage, and ongoing expenditure for stringent regulatory compliance and highly skilled personnel. The cumulative financial commitment for such operations is substantial.

Key Market Trends

The Global Biobanks Market is significantly shaped by the increasing prevalence of cord blood and stem cell banking. This trend is driven by growing awareness of stem cells' therapeutic potential across various medical conditions, including hematological disorders and certain cancers. The World Marrow Donor Association (WMDA) reported a substantial inventory of 760,832 cord blood units as of July 2024, demonstrating the scale of these specialized biobanking efforts. This growth is further supported by an expanding number of medical applications and ongoing research into regenerative medicine.

Key Market Players

• Danaher Corporation
• Merck KgaA
• Becton, Dickinson, and Company
• Avantor, Inc.
• Thermo Fisher Scientific, Inc
• Tecan Trading AG
• QIAGEN N.V.
• Hamilton Company
• ProMedDx, LLC
• ISENET Biobanking S.r.l

Report Scope:

In this report, the Global Biobanks Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biobanks Market, By Type:

• Disease Oriented Biobanks
• Population Based Biobanks
• Tissue Biobanks
• Others

Biobanks Market, By Sample Type:

• Blood Products
• Biological Fluids
• Nucleic Acid
• Cell Lines
• Others

Biobanks Market, By Application:

• Therapeutics
• Drug Discovery
• Clinical Diagnostics
• Clinical Research

Biobanks Market, By End User:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Others

Biobanks Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biobanks Market.

Available Customizations:

Global Biobanks Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biobanks Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Disease Oriented Biobanks, Population Based Biobanks, Tissue Biobanks, Others)
  • 5.2.2. By Sample Type (Blood Products, Biological Fluids, Nucleic Acid, Cell Lines, Others)
  • 5.2.3. By Application (Therapeutics, Drug Discovery, Clinical Diagnostics, Clinical Research)
  • 5.2.4. By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Biobanks Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Sample Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biobanks Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Sample Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Biobanks Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Sample Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Biobanks Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Sample Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Biobanks Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Sample Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biobanks Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Sample Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Biobanks Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Sample Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Biobanks Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Sample Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Biobanks Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Sample Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Biobanks Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Sample Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Biobanks Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Sample Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biobanks Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Sample Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Biobanks Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Sample Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Biobanks Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Sample Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Biobanks Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Sample Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Biobanks Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Sample Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Biobanks Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Sample Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biobanks Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Sample Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Biobanks Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Sample Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Biobanks Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Sample Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Biobanks Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Sample Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biobanks Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Sample Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Biobanks Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Sample Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Biobanks Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Sample Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biobanks Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Danaher Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merck KgaA
• 15.3. Becton, Dickinson, and Company
• 15.4. Avantor, Inc.
• 15.5. Thermo Fisher Scientific, Inc
• 15.6. Tecan Trading AG
• 15.7. QIAGEN N.V.
• 15.8. Hamilton Company
• 15.9. ProMedDx, LLC
• 15.10. ISENET Biobanking S.r.l

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료